Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H14N2O |
| Molecular Weight | 178.231 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)C(=O)C1=CC=CN=C1
InChI
InChIKey=NCYVXEGFNDZQCU-UHFFFAOYSA-N
InChI=1S/C10H14N2O/c1-3-12(4-2)10(13)9-6-5-7-11-8-9/h5-8H,3-4H2,1-2H3
| Molecular Formula | C10H14N2O |
| Molecular Weight | 178.231 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.rlsnet.ru/mnn_index_id_730.htm
Sources: https://www.rlsnet.ru/mnn_index_id_730.htm
Nikethamide is a respiratory and circulatory stimulant with some central nervous system activity. Widely known by its former trade name of Coramine, it was used in the mid-twentieth century as a medical countermeasure against tranquilizer overdoses, before the advent of endotracheal intubation and positive-pressure lung expansion. Nikethamide is available as a short-acting over-the-counter drug in several South American and European countries, combined with glucose in form of lozenges. Nikethamide is especially useful for mountain climbers to increase endurance at high altitudes. Contraindications include hypertension, cardiovascular pathologies, and epilepsy. In some sports, nikethamide is listed by the World Anti-Doping Agency as a banned substance. Croatian tennis player Marin Čilić was suspended from competition for nine months after he tested positive for nikethamide in April 2013
CNS Activity
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.rlsnet.ru/mnn_index_id_730.htm |
Primary | Coramine Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Epidemiological analysis of doping offences in the professional tennis circuit. | 2010-12-15 |
|
| Tetra-kis[μ-4-(diethyl-amino)-benzoato-κO:O']bis-[(N,N-diethyl-nicotinamide-κN)cobalt(II)]. | 2010-12-04 |
|
| Leaf and floral parts feeding by orange tip butterfly larvae depends on larval position but not on glucosinolate profile or nitrogen level. | 2010-12 |
|
| Evolution of diversity in Albugo is driven by high host specificity and multiple speciation events on closely related Brassicaceae. | 2010-11 |
|
| Isolation and structure elucidation of 5'-O-beta-D-glucopyranosyl-dihydroascorbigen from Cardamine diphylla rhizome. | 2010-09-03 |
|
| Hydrotropic solubilization of poorly water-soluble drugs. | 2010-09 |
|
| Diaqua-bis-(2-bromo-benzoato-κO)bis-(N,N-diethyl-nicotinamide-κN)cobalt(II). | 2010-08-18 |
|
| Differentiating Arabidopsis shoots from leaves by combined YABBY activities. | 2010-07 |
|
| A complex case of simple leaves: indeterminate leaves co-express ARP and KNOX1 genes. | 2010-06 |
|
| Diaqua-bis(N,N-diethyl-nicotinamide-κN)bis-(4-methyl-benzoato-κO)cobalt(II). | 2010-04-21 |
|
| Tetra-kis(μ-4-methyl-benzoato-κO:O')bis-[(N,N-diethyl-nicotinamide-κN)zinc(II)]. | 2010-03-31 |
|
| Novel antagonistic interactions associated with plant polyploidization influence trait selection and habitat preference. | 2010-03 |
|
| Endophytic fungi diversity of aquatic/riparian plants and their antifungal activity in vitro. | 2010-02 |
|
| Cytotype diversity and genome size variation in eastern Asian polyploid Cardamine (Brassicaceae) species. | 2010-02 |
|
| Weeds of change: Cardamine hirsuta as a new model system for studying dissected leaf development. | 2010-01 |
|
| Molecular cloning and characterization of a KCS gene from Cardamine graeca and its heterologous expression in Brassica oilseeds to engineer high nervonic acid oils for potential medical and industrial use. | 2009-12 |
|
| Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study. | 2009-12 |
|
| Tetra-kis[μ-4-(dimethyl-amino)benzoato-κO:O']bis-[(N,N-diethyl-nicotinamide-κN)zinc(II)]. | 2009-11-14 |
|
| Tetra-kis[μ-4-(methyl-amino)-benzoato-κO:O']bis-[(N,N-diethyl-nicotinamide-N)zinc(II)] dihydrate. | 2009-10-10 |
|
| Application of the isolation with migration model demonstrates the pleistocene origin of geographic differentiation in Cardamine nipponica (Brassicaceae), an endemic Japanese alpine plant. | 2009-10 |
|
| Diaqua-bis-(N,N-diethyl-nicotinamide-κN)bis[4-(dimethyl-amino)-benzoato-κO]cobalt(II). | 2009-08-08 |
|
| Diaqua-bis(N,N-diethyl-nicotinamide-κN)bis-[4-(dimethyl-amino)benzoato-κO]nickel(II). | 2009-07-31 |
|
| Tetra-kis[μ-4-(diethyl-amino)benzoato-κO:O']bis-[(N,N-diethyl-nicotinamide-κN)zinc(II)]. | 2009-07-18 |
|
| Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia. | 2009-07-08 |
|
| Diaqua-bis(2-bromo-benzoato-κO)bis-(N,N-diethyl-nicotinamide-κN)nickel(II). | 2009-06-13 |
|
| Molecular evolution of phytochromes in Cardamine nipponica (Brassicaceae) suggests the involvement of PHYE in local adaptation. | 2009-06 |
|
| Comment on 'Laparoscopic heminephroureterectomy for duplex kidney anomalies in the pediatric population' by J. Seibold, D. Schilling, U. Nagele, A.G. Anastasiadis, K.D. Sievert, A. Stenzl, S. Corvin. J Pediatr Urol 2008;4:345-7. | 2009-06 |
|
| Diaqua-bis(2-chloro-benzoato-κO)bis-(N,N-diethyl-nicotinamide-κN)nickel(II). | 2009-04-22 |
|
| Diaqua-bis(2-bromo-benzoato-κO)bis-(N,N-diethyl-nicotinamide-κN)manganese(II). | 2009-04-18 |
|
| Diaqua-bis(2-chloro-benzoato-κO)bis-(N,N-diethyl-nicotinamide-κN)manganese(II). | 2009-04-10 |
|
| Diaqua-bis(2-bromo-benzoato-κO)bis-(N,N-diethyl-nicotinamide-κN)zinc(II). | 2009-04-02 |
|
| Diaqua-bis(N,N-diethyl-nicotinamide-κN)bis-(4-formyl-benzoato-κO)cobalt(II). | 2009-03-11 |
|
| Comparison of light harvesting and resource allocation strategies between two rhizomatous herbaceous species inhabiting deciduous forests. | 2009-03 |
|
| Diaqua-bis(N,N-diethyl-nicotinamide-κN)bis-(4-formyl-benzoato-κO)nickel(II). | 2009-02-25 |
|
| Diaqua-bis(N,N-diethyl-nicotinamide-κN)bis-(4-formyl-benzoato-κO)manganese(II). | 2009-02-25 |
|
| A conserved molecular framework for compound leaf development. | 2008-12-19 |
|
| A cross-species transcriptomics approach to identify genes involved in leaf development. | 2008-12-05 |
|
| A developmental framework for dissected leaf formation in the Arabidopsis relative Cardamine hirsuta. | 2008-09 |
|
| Diaquabis(4-bromo-benzoato-κO)-bis(N,N'-diethyl-nicotinamide-κN)zinc(II). | 2008-08-30 |
|
| Mental state decoding v. mental state reasoning as a mediator between cognitive and social function in psychosis. | 2008-07 |
|
| Consistent geographic structure among multiple nuclear sequences and cpDNA polymorphisms of Cardamine nipponica Franch. et Savat. (Brassicaceae). | 2008-07 |
|
| [Role of 5-HT(2A) receptor in increase in respiratory-related rhythmic discharge activity by nikethamide in neonatal rat transverse medullary slices]. | 2008-04-25 |
|
| [GABA A receptor participates in respiratory enhancement induced by nikethamide in neonatal rats]. | 2008-03 |
|
| Diaqua-bis(4-chloro-benzoato-κO)bis-(N,N-diethyl-nicotinamide-κN)manganese(II). | 2008-02-29 |
|
| The correct interpretation and lectotypification of the name Cardamine fallax (Brassicaceae). | 2007-09 |
|
| Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. | 2007-06-28 |
|
| Hybridization between two polyploid Cardamine (Brassicaceae) species in North-western Spain: discordance between morphological and genetic variation patterns. | 2007-06 |
|
| Butterfly seed predation: effects of landscape characteristics, plant ploidy level and population structure. | 2007-05 |
|
| Impact of foliar herbivory on the development of a root-feeding insect and its parasitoid. | 2007-05 |
|
| Origin of the disjunct tetraploid Cardamine amporitana (Brassicaceae) assessed with nuclear and chloroplast DNA sequence data. | 2004-08 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.rlsnet.ru/tn_index_id_4630.htm
administered to adults in a dose of 1-2 ml 1-3 times a day, children under the skin - 0.1-0.75 ml
Route of Administration:
Other
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:46:45 GMT 2025
by
admin
on
Mon Mar 31 17:46:45 GMT 2025
|
| Record UNII |
368IVD6M32
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
R07AB02
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
||
|
WHO-VATC |
QR07AB02
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
||
|
NCI_THESAURUS |
C47795
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
||
|
WHO-ATC |
R07AB52
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
130820
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
DTXSID9046524
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
D009552
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
DB13655
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
59-26-7
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
100000091927
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
C76625
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
NIKETHAMIDE
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
5497
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
200-418-5
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
m7897
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | Merck Index | ||
|
7424
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB09286MIG
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
403
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104607
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
3383
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY | |||
|
368IVD6M32
Created by
admin on Mon Mar 31 17:46:45 GMT 2025 , Edited by admin on Mon Mar 31 17:46:45 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |